StockWatch
·

INDO COUNT INDUSTRIES LTD.

BSE: 521016

P/L Snapshot

Q1 FY27 · standalone

vs Q3 FY26·vs Q1 FY26
Revenue
839.72
+5.8%+12.8%
Expenditure
748.85
-1.4%+8.4%
Net Profit
66.78
+164.2%+65.8%
OPM %
13.86%
+5.74pp+1.89pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00287.94575.87863.811.2KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27
Price Chart
Reports

Indo Count Q1 FY27: consolidated PAT +67% YoY to ₹63 Cr as margins expand toward guidance

textiles · home textiles · margin expansion

ResultsQ1 FY2712 Aug 20263 minConsumer & Retail

Flooding Headwind in the Mix; Expansion Capex in Motion

textiles · earnings · capex

Result previewQ1 FY2711 Aug 20263 minConsumer & Retail

When Waters Rise: Western India's Factory Shutdowns

flooding · western india · operational disruption

ResearchCatalyst check25 Jul 20266 minIndustrials & Infra
Latest
Quarterly Result12 Aug, 2:29 pm

Indo Count Q1 FY27: consolidated PAT +67% YoY to ₹63 Cr as margins expand toward guidance

Indo Count Industries' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue came in at ₹1,206.96 Cr, up 25.9% YoY from ₹958.71 Cr and 14.1% QoQ from ₹1,057.68 Cr. Consolidated PAT was ₹63.22 Cr, up 67.3% YoY (₹37.79 Cr reported / ~62% on the ₹39.02 Cr restated base) and up 161% QoQ off a weak ₹24.20 Cr Q4 FY26 base — the QoQ jump is largely a base effect against a soft prior quarter rather than a fresh sequential acceleration, so the YoY read is the one to anchor on. Standalone told a similar story: revenue ₹819.44 Cr and PAT ₹66.78 Cr (EPS ₹3.37), actually ahead of the consolidated PAT of ₹63.22 Cr (EPS ₹3.19) because overseas subsidiaries collectively posted a small net loss (~₹3.39 Cr) this quarter per the auditor's review report — standalone and consolidated tell the same directional story, just with that overseas drag on the consol number. Margins expanded on both counts: consolidated NPM rose to ~5.2% from ~3.9% a year ago, and EBITDA margin (OPM) to ~13.3% from ~11.5-12.5%. That expansion lines up with what management flagged on the last concall (Feb 2026) — a gradual march toward its 15-16% EBITDA target as tariff-related pressure eases and ~150-200bps of new-business incubation costs get eliminated starting this exact quarter, Q1 FY27. The margin move is roughly in that range, so this quarter's print looks like management delivering on that specific near-term promise, even though the 15-16% steady-state target itself remains some distance away. No formal brokerage consensus for the quarter turned up in search; the one projection found (Univest/Uniresearch, a trailing-growth model, not a brokerage note) had pegged revenue near ₹977 Cr (+2% YoY) and PAT near ₹20 Cr (-50% YoY) — the actual print beat that bar comfortably on both lines, though given the source isn't a real street consensus this should be read as a beat against a weak bar rather than a confirmed Street beat. Management gives no explicit quantified guidance for this specific quarter beyond the margin-recovery and incubation-cost commentary noted above; the longer-term FY28 revenue-doubling plan (new segments contributing ~$275 million) isn't independently verifiable this quarter since the company still reports a single textile segment with no sub-segment breakout. Corporate developments this quarter were largely administrative — BRSR filing, 37th AGM notice — except for the Bhilad (Gujarat) facility flooding since July 23, 2026, which management has flagged as a non-adjusting event with an insurance claim assessment in progress and no P&L effect recorded yet. Separately, the board is still seeking shareholder approval for ₹2.96 Cr of FY26 managerial remuneration paid above Schedule V limits. Going into Q2 FY27, the two things to track are whether the OPM trajectory keeps closing toward the 15-16% target as incubation costs fully roll off, and whether the Bhilad disruption shows up as a cost or volume drag once the insurance assessment concludes.

12 Aug 2026, 02:29 pm

Corporate Events

Board MeetingICIL
2026
25Aug

Board Meeting

The 37th Annual General Meeting will be held to adopt financ…

BSE Filing
DividendICIL
2026
18Aug

₹1.5 / share

BSE Filing
Board MeetingICIL
2026
12Aug

Board Meeting

The Board of Directors will consider and approve the Unaudit…

BSE Filing
Board MeetingICIL
2026
30May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing
Board MeetingICIL
2026
13Feb

Board Meeting

consider and approve Unaudited Standalone Financial Results

BSE Filing
Board MeetingICIL
2025
11Nov

Board Meeting

consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingICIL
2025
12Aug

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingICIL
2025
30May

Board Meeting

consider and approve the Audited Standalone and Consolidated…

BSE Filing
Board MeetingICIL
2025
11Feb

Board Meeting

consider and approve Unaudited Standalone Financial Results,…

BSE Filing
Board MeetingICIL
2024
7Nov

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingICIL
2024
29Jul

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingICIL
2024
29Jan

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingICIL
2023
7Aug

Board Meeting

Consider and approve the Unaudited Standalone and Consolidat…

BSE Filing